The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents

The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents

Direct-acting antiviral agents (DAAs) have been widely used for chronic hepatitis C (CHC) treatment recently. The characteristics of glucose abnormalities after DAAs therapy however, remain elusive. We aimed to elucidate the mutual impact between treatment response and parameters of glucose abnormal...

Full description

Bibliographic Details
Main Authors: Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Meng-Hsuan Hsieh, Jeng-Fu Yang, Ching-I. Huang, Yi-Hung Lin, Po-Cheng Liang, Zu-Yau Lin, Shinn-Chern Chen, Ming-Lung Yu, Wan-Long Chuang
Format: Article
Language:English
Published: Wiley 2017-11-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Hepatitis C virus
Direct antiviral agents
Insulin resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S1607551X17302760

Internet

http://www.sciencedirect.com/science/article/pii/S1607551X17302760

Similar Items